Glycolipid depletion in antimicrobial therapy.

Glycolipid depletion in antimicrobial therapy.

Mucosal pathogens target sites of infection through specific adherence to host glycoconjugate receptors. As a consequence, depletion of such receptors from the cell surface may be expected to inhibit attachment, impair bacterial colonization and reduce the activation of mucosal inflammation. We have...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Svensson, M, Frendeus, B, Butters, T, Platt, F, Dwek, R, Svanborg, C
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	2003

Gelijkaardige items

Glycolipid receptor depletion as an approach to specific antimicrobial therapy.
door: Svensson, M, et al.
Gepubliceerd in: (2006)

Carbohydrate receptor depletion as an antimicrobial strategy for prevention of urinary tract infection.
door: Svensson, M, et al.
Gepubliceerd in: (2001)

Glycolipids in cell biology and medicine - Introduction
door: Dwek, R, et al.
Gepubliceerd in: (2003)

Small-molecule therapeutics for the treatment of glycolipid lysosomal storage disorders.
door: Butters, T, et al.
Gepubliceerd in: (2003)

Inhibition of substrate synthesis as a strategy for glycolipid lysosomal storage disease therapy.
door: Platt, F, et al.
Gepubliceerd in: (2001)

Glycosphingolipid lysosomal storage diseases: therapy and pathogenesis.
door: Jeyakumar, M, et al.
Gepubliceerd in: (2002)

Imino sugar therapy for type 1 Gaucher disease.
door: Priestman, D, et al.
Gepubliceerd in: (2000)

Contributions of Glycolipid Biosurfactants and Glycolipid-Modified Materials to Antimicrobial Strategy: A Review
door: Qin Shu, et al.
Gepubliceerd in: (2021-02-01)

CD1d presentation of glycolipids.
door: Speak, A, et al.
Gepubliceerd in: (2008)

Pharmacotherapeutic strategies using small molecules for the treatment of glycolipid lysosomal storage disorders.
door: Butters, T
Gepubliceerd in: (2007)

Therapeutic applications of imino sugars in lysosomal storage disorders.
door: Butters, T, et al.
Gepubliceerd in: (2003)

New therapeutics for the treatment of glycosphingolipid lysosomal storage diseases.
door: Butters, T, et al.
Gepubliceerd in: (2003)

Imino sugar inhibitors for treating the lysosomal glycosphingolipidoses.
door: Butters, T, et al.
Gepubliceerd in: (2005)

Inhibition of glycosphingolipid biosynthesis: application to lysosomal storage disorders.
door: Butters, T, et al.
Gepubliceerd in: (2000)

Iminosugar inhibitors for treating the lysosomal glycosphingolipidoses
door: Butters, T, et al.
Gepubliceerd in: (2005)

Substrate reduction therapy in mouse models of the glycosphingolipidoses.
door: Platt, F, et al.
Gepubliceerd in: (2003)

Introduction
door: Dwek, R, et al.
Gepubliceerd in: (2003)

Storage solutions: treating lysosomal disorders of the brain.
door: Jeyakumar, M, et al.
Gepubliceerd in: (2005)

Glycolipids/
door: Wiegandt, H.
Gepubliceerd in: (1985)

Membrane disruption and cytotoxicity of hydrophobic N-alkylated imino sugars is independent of the inhibition of protein and lipid glycosylation.
door: Mellor, H, et al.
Gepubliceerd in: (2003)

Targeting glycosylation as a therapeutic approach.
door: Dwek, R, et al.
Gepubliceerd in: (2002)

N-butyldeoxygalactonojirimycin: a more selective inhibitor of glycosphingolipid biosynthesis than N-butyldeoxynojirimycin, in vitro and in vivo.
door: Andersson, U, et al.
Gepubliceerd in: (2000)

Control of Alicyclobacillus acidoterrestris in Apple Juice with Natural Antimicrobial Glycolipid
door: Rory Wang, et al.
Gepubliceerd in: (2025-02-01)

Substrate reduction therapy
door: Platt, F, et al.
Gepubliceerd in: (2007)

Modulation of THP-1 macrophage and cholesterol-loaded foam cell apolipoprotein E levels by glycosphingolipids.
door: Garner, B, et al.
Gepubliceerd in: (2002)

Improved outcome of N-butyldeoxygalactonojirimycin-mediated substrate reduction therapy in a mouse model of Sandhoff disease.
door: Andersson, U, et al.
Gepubliceerd in: (2004)

The liganding of glycolipid transfer protein is controlled by glycolipid acyl structure.
door: Lucy Malinina, et al.
Gepubliceerd in: (2006-11-01)

Tuning the antimicrobial activity of microbial glycolipid biosurfactants through chemical modification
door: Melike Pala, et al.
Gepubliceerd in: (2024-02-01)

New developments in treating glycosphingolipid storage diseases.
door: Platt, F, et al.
Gepubliceerd in: (2005)

Glycosylation: disease targets and therapy.
door: Zitzmann, N, et al.
Gepubliceerd in: (2005)

High-performance cation-exchange chromatography and pulsed amperometric detection for the separation, detection, and quantitation of N-alkylated imino sugars in biological samples.
door: Mellor, H, et al.
Gepubliceerd in: (2000)

Inhibition of glycogen breakdown by imino sugars in vitro and in vivo.
door: Andersson, U, et al.
Gepubliceerd in: (2004)

Soluble human TLR2 ectodomain binds diacylglycerol from microbial lipopeptides and glycolipids.
door: Jiménez-Dalmaroni, M, et al.
Gepubliceerd in: (2015)

Glycolipids : new research /
door: Sasaki, Daiki
Gepubliceerd in: (c200)

Inhibition of glucosylceramide synthase does not reverse drug resistance in cancer cells.
door: Norris-Cervetto, E, et al.
Gepubliceerd in: (2004)

Enhanced survival in Sandhoff disease mice receiving a combination of substrate deprivation therapy and bone marrow transplantation.
door: Jeyakumar, M, et al.
Gepubliceerd in: (2001)

Long-term non-hormonal male contraception in mice using N-butyldeoxynojirimycin.
door: Walden, C, et al.
Gepubliceerd in: (2006)

Synergistic Treatment of Breast Cancer by Combining the Antimicrobial Peptide Piscidin with a Modified Glycolipid
door: Rebecca T. Miceli, et al.
Gepubliceerd in: (2024-07-01)

Pyroelectric detection in glycolipid thin film
door: Kwong, W.L., et al.
Gepubliceerd in: (2010)

Pharmacological impairment of acrosome formation and sperm head morphogenesis reveals essential role of glycosphingolipids in spermiogenesis
door: van der Spoel, A, et al.
Gepubliceerd in: (2002)